These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

801 related items for PubMed ID: 15364002

  • 1. Opioid profiles of Cys2-containing enkephalin analogues.
    Pencheva N, Milanov P, Vezenkov L, Pajpanova T, Naydenova E.
    Eur J Pharmacol; 2004 Sep 13; 498(1-3):249-56. PubMed ID: 15364002
    [Abstract] [Full Text] [Related]

  • 2. [Cys(O2NH2)2]enkephalin analogues and dalargin: selectivity for delta-opioid receptors.
    Pencheva N, Bocheva A, Dimitrov E, Ivancheva C, Radomirov R.
    Eur J Pharmacol; 1996 May 23; 304(1-3):99-108. PubMed ID: 8813590
    [Abstract] [Full Text] [Related]

  • 3. In vitro potency, affinity and agonist efficacy of highly selective delta opioid receptor ligands.
    Kramer TH, Davis P, Hruby VJ, Burks TF, Porreca F.
    J Pharmacol Exp Ther; 1993 Aug 23; 266(2):577-84. PubMed ID: 8394911
    [Abstract] [Full Text] [Related]

  • 4. Probes for narcotic receptor-mediated phenomena. 25. Synthesis and evaluation of N-alkyl-substituted (alpha-piperazinylbenzyl)benzamides as novel, highly selective delta opioid receptor agonists.
    Katsura Y, Zhang X, Homma K, Rice KC, Calderon SN, Rothman RB, Yamamura HI, Davis P, Flippen-Anderson JL, Xu H, Becketts K, Foltz EJ, Porreca F.
    J Med Chem; 1997 Aug 29; 40(18):2936-47. PubMed ID: 9288176
    [Abstract] [Full Text] [Related]

  • 5. Evolution of the Dmt-Tic pharmacophore: N-terminal methylated derivatives with extraordinary delta opioid antagonist activity.
    Salvadori S, Balboni G, Guerrini R, Tomatis R, Bianchi C, Bryant SD, Cooper PS, Lazarus LH.
    J Med Chem; 1997 Sep 12; 40(19):3100-8. PubMed ID: 9301674
    [Abstract] [Full Text] [Related]

  • 6. Synthesis, opioid receptor binding, and biological activities of naltrexone-derived pyrido- and pyrimidomorphinans.
    Ananthan S, Kezar HS, Carter RL, Saini SK, Rice KC, Wells JL, Davis P, Xu H, Dersch CM, Bilsky EJ, Porreca F, Rothman RB.
    J Med Chem; 1999 Sep 09; 42(18):3527-38. PubMed ID: 10479286
    [Abstract] [Full Text] [Related]

  • 7. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
    Ananthan S, Johnson CA, Carter RL, Clayton SD, Rice KC, Xu H, Davis P, Porreca F, Rothman RB.
    J Med Chem; 1998 Jul 16; 41(15):2872-81. PubMed ID: 9667975
    [Abstract] [Full Text] [Related]

  • 8. [D-Pen2,D-Pen5]enkephalin analogues with increased affinity and selectivity for delta opioid receptors.
    Toth G, Kramer TH, Knapp R, Lui G, Davis P, Burks TF, Yamamura HI, Hruby VJ.
    J Med Chem; 1990 Jan 16; 33(1):249-53. PubMed ID: 2153205
    [Abstract] [Full Text] [Related]

  • 9. Side chain methyl substitution in the delta-opioid receptor antagonist TIPP has an important effect on the activity profile.
    Tourwé D, Mannekens E, Diem TN, Verheyden P, Jaspers H, Tóth G, Péter A, Kertész I, Török G, Chung NN, Schiller PW.
    J Med Chem; 1998 Dec 17; 41(26):5167-76. PubMed ID: 9857087
    [Abstract] [Full Text] [Related]

  • 10. Identification of mechanisms and sites of actions of mu and delta opioid receptor activation in the canine intestine.
    Fox-Threlkeld JE, Daniel EE, Christinck F, Hruby VJ, Cipris S, Woskowska Z.
    J Pharmacol Exp Ther; 1994 Feb 17; 268(2):689-700. PubMed ID: 8113980
    [Abstract] [Full Text] [Related]

  • 11. Probes for narcotic receptor mediated phenomena. 23. Synthesis, opioid receptor binding, and bioassay of the highly selective delta agonist (+)-4-[(alpha R)-alpha-((2S,5R)-4-Allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]- N,N-diethylbenzamide (SNC 80) and related novel nonpeptide delta opioid receptor ligands.
    Calderon SN, Rice KC, Rothman RB, Porreca F, Flippen-Anderson JL, Kayakiri H, Xu H, Becketts K, Smith LE, Bilsky EJ, Davis P, Horvath R.
    J Med Chem; 1997 Feb 28; 40(5):695-704. PubMed ID: 9057856
    [Abstract] [Full Text] [Related]

  • 12. De novo design, synthesis, and biological activities of high-affinity and selective non-peptide agonists of the delta-opioid receptor.
    Liao S, Alfaro-Lopez J, Shenderovich MD, Hosohata K, Lin J, Li X, Stropova D, Davis P, Jernigan KA, Porreca F, Yamamura HI, Hruby VJ.
    J Med Chem; 1998 Nov 19; 41(24):4767-76. PubMed ID: 9822547
    [Abstract] [Full Text] [Related]

  • 13. Pharmacologic evaluation of a cyclic somatostatin analog with antagonist activity at mu opioid receptors in vitro.
    Shook JE, Pelton JT, Wire WS, Hirning LD, Hruby VJ, Burks TF.
    J Pharmacol Exp Ther; 1987 Mar 19; 240(3):772-7. PubMed ID: 2882015
    [Abstract] [Full Text] [Related]

  • 14. Dynorphin A(1-8): stability and implications for in vitro opioid activity.
    Bell KM, Traynor JR.
    Can J Physiol Pharmacol; 1998 Mar 19; 76(3):325-33. PubMed ID: 9673796
    [Abstract] [Full Text] [Related]

  • 15. Structure-activity relationships for SNC80 and related compounds at cloned human delta and mu opioid receptors.
    Knapp RJ, Santoro G, De Leon IA, Lee KB, Edsall SA, Waite S, Malatynska E, Varga E, Calderon SN, Rice KC, Rothman RB, Porreca F, Roeske WR, Yamamura HI.
    J Pharmacol Exp Ther; 1996 Jun 19; 277(3):1284-91. PubMed ID: 8667189
    [Abstract] [Full Text] [Related]

  • 16. Opioid antagonist properties of the highly delta-receptor-selective BOC-Tyr-Pro-Gly-Phe-Leu-Thr (OtBu) peptide and of its Phe1 and Mel1 analogues.
    Rónai AZ, Magyar A, Orosz G, Borsodi A, Benyhe S, Tóth G, Makó E, Kátay E, Babka E, Medzihradszky K.
    Arch Int Pharmacodyn Ther; 1995 Jun 19; 330(3):361-9. PubMed ID: 8836454
    [Abstract] [Full Text] [Related]

  • 17. Evidence for lack of modulation of mu-opioid agonist action by delta-opioid agonists in the mouse vas deferens and guinea-pig ileum.
    Elliott J, Traynor JR.
    Br J Pharmacol; 1995 Mar 19; 114(5):1064-8. PubMed ID: 7780641
    [Abstract] [Full Text] [Related]

  • 18. Effects of structural modifications of N-CPM-normorphine derivatives on agonist and antagonist activities in isolated organs.
    Riba P, Tóth Z, Hosztafi S, Friedmann T, Fürst S.
    Acta Biol Hung; 2003 Mar 19; 54(2):177-81. PubMed ID: 14535623
    [Abstract] [Full Text] [Related]

  • 19. A novel phencyclidine analog interacts selectively with mu opioid receptors.
    Itzhak Y, Simon EJ.
    J Pharmacol Exp Ther; 1984 Aug 19; 230(2):383-6. PubMed ID: 6086884
    [Abstract] [Full Text] [Related]

  • 20. Effect of aromatic amino acid substitutions in the 3-position of cyclic beta-casomorphin analogues on mu-opioid agonist/delta-opioid antagonist properties.
    Schmidt R, Wilkes BC, Chung NN, Lemieux C, Schiller PW.
    Int J Pept Protein Res; 1996 Nov 19; 48(5):411-9. PubMed ID: 8956074
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.